| Randomized, placebo-controlled, phase III trial of fosaprepitant, ondansetron, dexamethasone (FOND) versus FOND plus olanzapine (FOND-O) for the prevention of chemotherapy … AB Clemmons, J Orr, B Andrick, A Gandhi, C Sportes, D DeRemer Biology of Blood and Marrow Transplantation 24 (10), 2065-2071, 2018 | 49 | 2018 |
| Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib. B Andrick, A Alwhaibi, DL DeRemer, S Quershi, R Khan, LJ Bryan, ... British journal of haematology 182 (5), 712-714, 2017 | 47 | 2017 |
| Olaratumab: a novel platelet-derived growth factor receptor α-inhibitor for advanced soft tissue sarcoma BJ Andrick, A Gandhi Annals of Pharmacotherapy 51 (12), 1090-1098, 2017 | 12 | 2017 |
| Current advances in Hodgkin’s lymphoma J Vadakara, B Andrick Chronic diseases and translational medicine 5 (1), 15-24, 2019 | 8 | 2019 |
| Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins BJ Andrick, AI Schwab, B Cauley, LA O’Donnell, WS Meng PloS one 10 (8), e0135451, 2015 | 8 | 2015 |
| Impact of a pharmacist-led telehealth oral chemotherapy clinic AD Mathur, TA Maiers, BJ Andrick American Journal of Health-System Pharmacy 79 (11), 896-903, 2022 | 7 | 2022 |
| Pharmacist value-added to neuro-oncology subspecialty clinics: a pilot study uncovers opportunities for best practices and optimal time utilization GW Lee, AD Mathur, BJ Andrick, E Leese, D Zally, NTN Gatson Journal of Oncology Pharmacy Practice 26 (8), 1937-1941, 2020 | 6 | 2020 |
| Gilteritinib: a novel FLT3 inhibitor for relapsed/refractory acute myeloid leukemia D Marjoncu, B Andrick Journal of the advanced practitioner in oncology 11 (1), 104, 2020 | 6 | 2020 |
| Antibody response to pneumococcal conjugate vaccine (PCV13) in chronic lymphocytic leukemia patients receiving ibrutinib B Andrick, A Alwhaibi, D DeRemer, S Quershi, R Khan, S Shenoy, ... Blood, The Journal of the American Society of Hematology 128 (22), 5597-5597, 2016 | 4 | 2016 |
| A bioinformatics practicum to develop student understanding of immunological rejection of protein drugs LA O’Donnell, WS Meng, BJ Andrick, AM Borello American Journal of Pharmaceutical Education 80 (9), 147, 2016 | 3 | 2016 |
| Oncology pharmacy practice in the United States: results of a comprehensive, nationwide survey SP Griffin, JR Signorelli, A Lasko, BJ Andrick, D Doan, S Hough, ... Journal of Oncology Pharmacy Practice 30 (2), 332-341, 2024 | 2 | 2024 |
| The impact of a hematopoietic cellular therapy pharmacist on clinical and humanistic outcomes: a RE-AIM framework analysis B Andrick, L Tusing, LK Jones, Y Hu, R Sneidman, C Gregor, S Basu, ... Transplantation and Cellular Therapy 28 (6), 334. e1-334. e9, 2022 | 2 | 2022 |
| Cancer-associated venous thromboembolism treatment with anti-Xa versus weight-based enoxaparin: a retrospective evaluation of safety and efficacy K Hart, B Andrick, S Grassi, J Manikowski, J Graham Annals of Pharmacotherapy 55 (9), 1120-1126, 2021 | 2 | 2021 |
| Clozapine drug-induced pancreatitis of intermediate latency of onset confirmed by de-challenge and re-challenge CE DeRemer, BJ Andrick, MD Capito International Journal of Clinical Pharmacology and Therapeutics 57 (1), 37, 2019 | 2 | 2019 |
| Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia L Okubo, B Andrick, R Rampulla, F Leri Journal of Oncology Pharmacy Practice 28 (4), 898-903, 2022 | 1 | 2022 |
| Pharmacist versus physician provider management of hydroxyurea therapy for polycythemia vera (PERMANACE) B Andrick, A Mathur, T Maiers, J Graham, J Vadakara Blood 136, 44-45, 2020 | 1 | 2020 |
| Demodex folliculorum infestation mimicking acute cutaneous GVHD S Tahir, J Vadakara, J Lynch, B Andrick, P Pathak, E Hossler, N Sebes, ... Biology of Blood and Marrow Transplantation 26 (3), S342, 2020 | 1 | 2020 |
| Design of a bioinformatics practicum aimed at integrating concepts in immunology, virology, and pharmaceutical sciences in pharmacy curricula (EDU1P. 253) L O'Donnell, B Andrick, W Meng The Journal of Immunology 192 (1_Supplement), 49.7-49.7, 2014 | 1 | 2014 |
| Stopping Oral Chemotherapy Agents With a High Bleeding Risk Before and After Minor Surgical Procedures. D Marjoncu, J Carmichael, BJ Andrick, J Oxenberg Journal of Hematology Oncology Pharmacy 13 (3), 2023 | | 2023 |
| Cancer patients' experience with a pharmacist‐led oral chemotherapy clinic: A qualitative descriptive study AN Hamner, B Andrick, A Mathur, MR Gionfriddo Journal of the American College of Clinical Pharmacy 6 (1), 24-28, 2023 | | 2023 |
